v3.26.1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 75,460 $ 69,189 $ 145,507 $ 125,776
General and administrative 17,934 40,454 35,224 55,250
Total operating expenses 93,394 109,643 180,731 181,026
Loss from operations (93,394) (109,643) (180,731) (181,026)
Interest income (expense), net 5,037 4,434 9,417 7,594
Other income (expense), net (52) (2) (53) (22)
Net loss and comprehensive loss (88,409) (105,211) (171,367) (173,454)
Impact of preferred stock extinguishments and modifications       (9,396)
Net loss attributable to common stockholders $ (88,409) $ (105,211) $ (171,367) $ (182,850)
Net loss per share attributable to common stockholders, basic $ (1.63) $ (36.94) $ (3.9) $ (65.08)
Net loss per share attributable to common stockholders, diluted $ (1.63) $ (36.94) $ (3.9) $ (65.08)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, Basic 54,143,162 2,848,529 43,978,373 2,809,691
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, Diluted 54,143,162 2,848,529 43,978,373 2,809,691